Technical Analysis for HOWL - Werewolf Therapeutics, Inc.

Grade Last Price % Change Price Change
C 17.07 3.83% 0.63
HOWL closed up 3.83 percent on Friday, October 15, 2021, on 1.63 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical HOWL trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Doji - Bearish? Reversal 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
50 DMA Resistance Bearish 3.83%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.83%
Up 3 Days in a Row Strength 3.83%
Stochastic Buy Signal Bullish 3.90%
Older End-of-Day Signals for HOWL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Werewolf Therapeutics, Inc. Description

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It offers PREDATOR, a platform of protein engineering technology to design and engineer the future of immuno-oncology biotherapeutics for patients. The company's lead product candidates include WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. It also develops WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Solid Tumors Health Sciences Treatment Of Cancer Cancer Immunotherapy Lymphoma Hematologic Malignancies Advanced Solid Tumors Metastatic Solid Tumors

Is HOWL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 23.99
52 Week Low 11.25
Average Volume 16,502
200-Day Moving Average 0.00
50-Day Moving Average 16.88
20-Day Moving Average 17.00
10-Day Moving Average 16.67
Average True Range 1.06
ADX 20.61
+DI 22.96
-DI 12.21
Chandelier Exit (Long, 3 ATRs) 15.05
Chandelier Exit (Short, 3 ATRs) 18.67
Upper Bollinger Bands 18.18
Lower Bollinger Band 15.82
Percent B (%b) 0.53
BandWidth 13.91
MACD Line -0.21
MACD Signal Line -0.14
MACD Histogram -0.0648
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.58
Resistance 3 (R3) 19.60 18.77 19.16
Resistance 2 (R2) 18.77 18.13 18.77 19.02
Resistance 1 (R1) 17.92 17.74 18.35 17.91 18.88
Pivot Point 17.10 17.10 17.31 17.09 17.10
Support 1 (S1) 16.25 16.46 16.67 16.23 15.26
Support 2 (S2) 15.42 16.06 15.42 15.12
Support 3 (S3) 14.57 15.42 14.98
Support 4 (S4) 14.56